Boosting the efficiency of single-cell RNA-sequencing helps reveal subtle differences between healthy and dysfunctional cells.
Michael Birnbaum, Anders Hansen, and Tami Lieberman receive NIH Director’s New Innovator Awards from the NIH Common Fund’s High-Risk, High-Reward Research program.
A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard Covid-19 diagnostic.
Those selected for these positions receive additional support to pursue their research and develop their careers.
MIT course on the Covid-19 pandemic, available to the public online, brings together top experts to educate students on up-to-date science.
MIT students explore algal water purifiers, programmable soil bacteria, and other biological engineering approaches to food and water security.
Unique survey of gene expression by cell type in humans and mice reveals several deficits affecting the most vulnerable neurons.
In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.
The startup ClosedLoop has created a platform of predictive models to help organizations improve patient care.
Knocking out the immune cytokine IL-6 exacerbates symptoms in HD model mice, affects neural connection genes.
Drug compound, tested in mice, could be effective in treating the leading heritable cause of intellectual disability and autism.
Multi-institutional MassCPR initiative announces more than $16.5 million to support 62 Boston-area projects.
New CRISPR-based research tool delivers results in an hour; researchers share protocol and kits to advance research and move toward clinical validation.